Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Atrion's Business Segments
Atrion's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of FY
Reportable Segments
-
Largest Segment
-
Total Revenue
$ 49
Regions Reported
2
Atrion does not report a distinct business-segment axis in its filings - its disaggregated revenue is disclosed by product and service category instead. See the Product & Service breakdown below.
Revenue Share by Region - FY
- All Other Regions21.1%
- European Union15.7%
Revenue by Geographic Region - FY
| Region | Revenue (Millions) | % of Total |
|---|---|---|
| All Other Regions | $ 10 | 21.1% |
| European Union | $ 8 | 15.7% |
Description of Atrion
Atrion Corporation is a healthcare company that focuses on developing and manufacturing medical devices and specialty products for various clinical applications. Established in 1944, the company was initially known as Allen-Simmons Corporation and later changed its name to Atrion Corporation in 1993, following a merger with Cardiovascular Products, Inc.
With its headquarters in Allen, Texas, Atrion Corporation has a significant global presence, with various subsidiaries and facilities in Canada, Europe, and Asia. The company has a diverse range of product lines, comprising of medical devices, intraocular lenses, inertial navigation systems, and other specialty products.
The medical device business unit of Atrion Corporation designs, develops, and manufactures a wide range of cardiovascular and fluid delivery products. These include catheters, valves, sheaths, introducers, and other devices used in diagnostic and interventional procedures. These devices offer healthcare professionals precise control and improved outcomes, making them the preferred choice in many clinical settings.
Additionally, Atrion Corporation's intraocular lens business unit focuses on the design and manufacturing of lenses used in cataract surgery. The lenses are made from high-quality materials that provide excellent optical clarity and patient comfort, leading to improved visual outcomes.
Another interesting aspect of Atrion Corporation's product line is its inertial navigation systems, which are used in the aerospace and defense industry. These systems are designed to provide accurate guidance and navigation information, making them critical components in various applications, including missile guidance, unmanned aerial systems, and spacecraft.
In terms of financials, Atrion Corporation generates revenues of approximately $155 million annually, with a net income of $38 million. The company is publicly traded on the NASDAQ stock exchange under the symbol "ATRI," and it has a market capitalization of approximately $1 billion.
Overall, Atrion Corporation is a healthcare company that has shown resilience and innovation, particularly in its medical device and intraocular lens product lines. Its dedication to precision, quality, and improved outcomes has made it a trusted name in the healthcare industry, positioning the company for continued growth and success.
With its headquarters in Allen, Texas, Atrion Corporation has a significant global presence, with various subsidiaries and facilities in Canada, Europe, and Asia. The company has a diverse range of product lines, comprising of medical devices, intraocular lenses, inertial navigation systems, and other specialty products.
The medical device business unit of Atrion Corporation designs, develops, and manufactures a wide range of cardiovascular and fluid delivery products. These include catheters, valves, sheaths, introducers, and other devices used in diagnostic and interventional procedures. These devices offer healthcare professionals precise control and improved outcomes, making them the preferred choice in many clinical settings.
Additionally, Atrion Corporation's intraocular lens business unit focuses on the design and manufacturing of lenses used in cataract surgery. The lenses are made from high-quality materials that provide excellent optical clarity and patient comfort, leading to improved visual outcomes.
Another interesting aspect of Atrion Corporation's product line is its inertial navigation systems, which are used in the aerospace and defense industry. These systems are designed to provide accurate guidance and navigation information, making them critical components in various applications, including missile guidance, unmanned aerial systems, and spacecraft.
In terms of financials, Atrion Corporation generates revenues of approximately $155 million annually, with a net income of $38 million. The company is publicly traded on the NASDAQ stock exchange under the symbol "ATRI," and it has a market capitalization of approximately $1 billion.
Overall, Atrion Corporation is a healthcare company that has shown resilience and innovation, particularly in its medical device and intraocular lens product lines. Its dedication to precision, quality, and improved outcomes has made it a trusted name in the healthcare industry, positioning the company for continued growth and success.
Atrion Corporation is a prominent developer and manufacturer known for its innovative medical devices and components that serve a wide range of healthcare industries across the globe. The company operates through three principal business segments: Cardiovascular, Fluid Delivery, and Ophthalmic. Each segment contributes uniquely to advancing healthcare solutions, focusing on improving patient outcomes, enhancing procedural efficiency, and ensuring safety.
1. Cardiovascular Segment:
The Cardiovascular segment of Atrion Corporation is dedicated to addressing challenges associated with cardiovascular diseases, such as atrial fibrillation, peripheral vascular disease, and coronary artery disease. The primary aim of this segment is to create advanced medical devices and software systems that help clinicians perform interventional procedures with enhanced accuracy and efficiency.
- Product Range: The cardiovascular product portfolio includes:
- Balloon Catheters: These devices are used for angioplasty procedures to open narrowed or blocked blood vessels and can be equipped with specialized features for various interventional techniques.
- Diagnostic Catheters: Used extensively for conducting diagnostic procedures by enabling access to the hearts chambers and the vascular system to assess conditions such as arrhythmias or vascular blockages.
- Stents: Atrions stents are designed to provide support to blood vessels after they have been treated with balloon angioplasty, preventing re-narrowing and improving blood flow.
- Occlusion Devices: These products are vital for blocking the flow of blood in specific areas, such as for managing certain medical conditions or during surgical procedures.
- Software Systems: The segment also includes software solutions that aid in image processing and catheter navigation, significantly improving the precision of cardiovascular interventions.
The ongoing research and development activities in this segment focus on enhancing the design and technology behind these products, aiming for better integration with digital health solutions and telemedicine.
Fluid Delivery Segment:
Atrions Fluid Delivery segment specializes in creating medical devices and components that facilitate safe and efficient fluid management across various healthcare applications. This segment is essential for a wide range of healthcare environments, including inpatient and outpatient settings.
- Product Range: Major offerings include:
- Tubing Sets: Designed for intravenous delivery and various fluid management solutions, every tubing set is manufactured to minimize the risk of leakage and contamination, ensuring patient safety.
- Valves: These devices are integral in regulating fluid flow, providing necessary control in various medical procedures.
- Catheters: A wide array of catheter types, such as central venous catheters and peripherally inserted central catheters (PICCs), are included in this segment to cater to different medical needs.
- Infection Control Devices: Products designed specifically to enhance safety by reducing the risk of hospital-acquired infections during fluid management procedures are a significant focus.
The Fluid Delivery segment emphasizes rigorous testing and adherence to global standards to ensure that the products meet the demanding requirements of healthcare professionals and enhance the overall patient care experience.
Ophthalmic Segment:
The Ophthalmic segment of Atrion Corporation specializes in creating advanced medical devices tailored for eye surgeries and the management of ocular diseases, particularly in the context of cataract surgeries.
- Product Range: Key offerings are as follows:
- Viscoelastic Solutions: These products are used during cataract surgery to maintain intraocular pressure and protect ocular tissues.
- Irrigation Solutions: Solutions designed for use in various eye surgeries, ensuring proper fluid management during surgical procedures.
- Anterior Chamber Cannulas: Essential for facilitating fluid entry into the anterior chamber of the eye during surgical interventions.
- Implant Injectors: Devices that allow for the precise and controlled delivery of ocular implants, such as intraocular lenses, into the eye.
- Vitreoretinal Surgical Instruments: A comprehensive array of specialized surgical instruments designed for complex retina procedures, aiding surgeons in performing delicate operations.
The focus in this segment is on developing innovative and ergonomic tools that enhance surgical precision and improve patient recovery times, contributing to better visual outcomes post-surgery.
Contract Manufacturing Services:
Beyond its three primary segments, Atrion Corporation also provides extensive contract manufacturing services to other medical device companies. These services encompass:
- Design and Prototyping: Collaborating closely with clients to develop and optimize product designs tailored to specific market needs.
- Engineering Services: Offering expertise in engineering processes to enhance product functionality and manufacturability.
- Manufacturing Services: Utilizing state-of-the-art manufacturing technologies in FDA-compliant facilities in New Jersey and Texas to produce high-quality medical devices.
Atrions commitment to quality, precision, and innovation permeates all these segments, ensuring that healthcare providers receive reliable and advanced solutions that meet global regulatory guidelines and improve patient care overall. The companys continuous investment in research and development reflects its mission to remain at the forefront of the medical device industry, responsive to the evolving needs and challenges faced by healthcare professionals worldwide.
1. Cardiovascular Segment:
The Cardiovascular segment of Atrion Corporation is dedicated to addressing challenges associated with cardiovascular diseases, such as atrial fibrillation, peripheral vascular disease, and coronary artery disease. The primary aim of this segment is to create advanced medical devices and software systems that help clinicians perform interventional procedures with enhanced accuracy and efficiency.
- Product Range: The cardiovascular product portfolio includes:
- Balloon Catheters: These devices are used for angioplasty procedures to open narrowed or blocked blood vessels and can be equipped with specialized features for various interventional techniques.
- Diagnostic Catheters: Used extensively for conducting diagnostic procedures by enabling access to the hearts chambers and the vascular system to assess conditions such as arrhythmias or vascular blockages.
- Stents: Atrions stents are designed to provide support to blood vessels after they have been treated with balloon angioplasty, preventing re-narrowing and improving blood flow.
- Occlusion Devices: These products are vital for blocking the flow of blood in specific areas, such as for managing certain medical conditions or during surgical procedures.
- Software Systems: The segment also includes software solutions that aid in image processing and catheter navigation, significantly improving the precision of cardiovascular interventions.
The ongoing research and development activities in this segment focus on enhancing the design and technology behind these products, aiming for better integration with digital health solutions and telemedicine.
Fluid Delivery Segment:
Atrions Fluid Delivery segment specializes in creating medical devices and components that facilitate safe and efficient fluid management across various healthcare applications. This segment is essential for a wide range of healthcare environments, including inpatient and outpatient settings.
- Product Range: Major offerings include:
- Tubing Sets: Designed for intravenous delivery and various fluid management solutions, every tubing set is manufactured to minimize the risk of leakage and contamination, ensuring patient safety.
- Valves: These devices are integral in regulating fluid flow, providing necessary control in various medical procedures.
- Catheters: A wide array of catheter types, such as central venous catheters and peripherally inserted central catheters (PICCs), are included in this segment to cater to different medical needs.
- Infection Control Devices: Products designed specifically to enhance safety by reducing the risk of hospital-acquired infections during fluid management procedures are a significant focus.
The Fluid Delivery segment emphasizes rigorous testing and adherence to global standards to ensure that the products meet the demanding requirements of healthcare professionals and enhance the overall patient care experience.
Ophthalmic Segment:
The Ophthalmic segment of Atrion Corporation specializes in creating advanced medical devices tailored for eye surgeries and the management of ocular diseases, particularly in the context of cataract surgeries.
- Product Range: Key offerings are as follows:
- Viscoelastic Solutions: These products are used during cataract surgery to maintain intraocular pressure and protect ocular tissues.
- Irrigation Solutions: Solutions designed for use in various eye surgeries, ensuring proper fluid management during surgical procedures.
- Anterior Chamber Cannulas: Essential for facilitating fluid entry into the anterior chamber of the eye during surgical interventions.
- Implant Injectors: Devices that allow for the precise and controlled delivery of ocular implants, such as intraocular lenses, into the eye.
- Vitreoretinal Surgical Instruments: A comprehensive array of specialized surgical instruments designed for complex retina procedures, aiding surgeons in performing delicate operations.
The focus in this segment is on developing innovative and ergonomic tools that enhance surgical precision and improve patient recovery times, contributing to better visual outcomes post-surgery.
Contract Manufacturing Services:
Beyond its three primary segments, Atrion Corporation also provides extensive contract manufacturing services to other medical device companies. These services encompass:
- Design and Prototyping: Collaborating closely with clients to develop and optimize product designs tailored to specific market needs.
- Engineering Services: Offering expertise in engineering processes to enhance product functionality and manufacturability.
- Manufacturing Services: Utilizing state-of-the-art manufacturing technologies in FDA-compliant facilities in New Jersey and Texas to produce high-quality medical devices.
Atrions commitment to quality, precision, and innovation permeates all these segments, ensuring that healthcare providers receive reliable and advanced solutions that meet global regulatory guidelines and improve patient care overall. The companys continuous investment in research and development reflects its mission to remain at the forefront of the medical device industry, responsive to the evolving needs and challenges faced by healthcare professionals worldwide.